Global Information
회사소개 | 문의 | 비교리스트

근육 자극기 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Muscle Stimulator Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2022년 01월 상품코드 995764
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,750 ₩ 6,306,000 PDF & Excel (Single User License)
US $ 5,250 ₩ 6,970,000 PDF & Excel (Team License: Up to 7 Users)
US $ 6,500 ₩ 8,630,000 PDF & Excel (Site License)
US $ 8,750 ₩ 11,617,000 PDF & Excel (Corporate License)


근육 자극기 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Muscle Stimulator Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
발행일 : 2022년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 근육 자극기 시장 규모는 예측기간 중 3.5%의 CAGR로 확대될 것으로 예측됩니다.

COVID 환자를 치료하기 위해서 많은 호흡근 자극기가 사용되고 있기 때문에 팬데믹은 시장에 약간의 플러스 영향을 미칩니다. 예를 들어 Liberate Medical의 VentFree 호흡근 자극기는 2020년 5월에 FDA의 긴급 승인을 받았습니다. 이 디바이스는 비침습적인 방법으로 자극을 제공하고, 치료를 인공호흡 개시 직후에 개시할 수 있어 환자가 인공호흡기로부터 이탈할 때까지 지속할 수 있습니다. 그로 인해 환자의 인공호흡 시간이 단축됩니다.

이것은 근골격계 장애 증가, 기술 진보, 스포츠 의학의 통증 관리 요법 강화 및 장애에 대한 물리요법사 사이에서의 기호 상승에 기인하고 있습니다. 근육 자극기는 근육 경련을 경감하고, 불쾌감이나 통증을 경감하고, 근육 긴장을 회복하고, 신체의 일부를 재활하는데 도움이 됩니다. 근육 자극기의 이 이점에 의해 물리요법사는 대상이 되는 환자의 치료에 자주 채용하고 있습니다. 또한 건강하지 못한 식사와 인구의 운동 부족은 근골격계 장애를 일으킵니다.

2018년에 발표된 기사 Sandul Yasobant에 의하면 근골격계 장애의 세계 유병률은 14%에서 42%입니다. 이러한 장애 발생률은 노인 인구가 보다 높고, 그 수는 극적으로 증가하고 있습니다.

2020년 United Nations Population Fund에 의하면 아시아태평양의 고령자수는 전례 없는 속도로 증가하고 있으며, 세계에서 가장 고령화가 진행되고 있습니다. 2050년까지 아시아태평양의 4명 중 1명이 60세 이상이 됩니다. 이 지역의 성인(60세 이상) 수는 2010-2050년간 3배가 되고, 추정 130만명에 달할 것입니다.

이러한 장애에 시달리는 많은 사람들 때문에 시장은 성장하고 있습니다. 또한 몇 가지 기술적으로 진행된 제품 발매는 시장 성장을 지지하고 있습니다. 예를 들어 2019년 OMRON Healthcare는 인도에서 OMRON의 경피적 전기 자극(TENS) 기술을 탑재한 전자 신경자극기(모델 HV-F013)를 발매했습니다. 수요 증가와 무선 휴대용 근육 자극기 채용 및 스마트폰과의 호환성에 의해 근육 자극기 시장에 풍부한 기회가 창출되고 있습니다.

세계의 근육 자극기(Muscle Stimulator) 시장에 대해 조사했으며, 시장 개요와 함께 제품 종류별, 모달리티별, 용도별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 추진력
    • 근골격계 장애 증가
    • 기술 진보
    • 물리요법사 사이에서 높아지는 기호
  • 시장 성장 억제요인
    • 비용 효율적 대체 요법의 이용 가능성
    • 엄격한 규제 방침과 안전상 우려
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 제품 종류별
    • 신경근 전기 자극
    • 기능적 전기 자극
    • 경피적 전기 자극
    • 간섭
    • 기타
  • 모달리티별
    • 핸드헬드
    • 휴대용
  • 용도별
    • 신경학적 장애
    • 통증 관리
    • 근골격계 장애
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동과 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • Beurer GmbH
    • NeuroMetrix, Inc
    • DJO Global
    • EMS Physio Ltd.
    • Zynex Medical
    • BioMedical Life Systems
    • Omron Healthcare, Inc
    • Liberate Medical
    • Innovative Health Solutions
    • Abbott Laboratories
    • RS Medical, Inc.
    • Mettler Electronics Corp
    • Tone-A-Matic
    • Zimmer MedizinSysteme GmbH
    • EMS Physio Ltd.

제7장 시장 기회와 동향

KSM 21.03.19

The muscle stimulator market is expected to register a CAGR of 3.5% during the forecast period, 2021-2026.

The pandemic has had a slightly positive impact on the market as there are many respiratory muscle stimulators getting launched used to treat patients with COVID-19. For instance, Liberate Medical's VentFree Respiratory Muscle Stimulator received FDA emergency approval in May 2020. The device delivers stimulation in a non-invasive fashion, and the therapy can be initiated immediately at the start of ventilation and continued until patients are weaned off ventilation. This reduces the time of ventilation of the patients.

This is attributing to increasing musculoskeletal disorders, technological advancement, emphasis on pain management therapies in sports medicine, and growing preference among physiotherapists for the disorders as muscle stimulators help in reducing muscle spasms, reduce discomfort and pain, restore muscle tone, and rehabilitate parts of the body. This advantage of muscles stimulator results in increasing adoption by a physiotherapist to treat the targeted patient pool. Moreover, unhealthy diets and lack of fitness activities among the population result in musculoskeletal disorders.

According to Sandul Yasobant in the article published in 2018, the global prevalence of musculoskeletal disorders ranges from 14% to as high as 42%. The incidence of these disorders increases as the geriatric population is at more risk, and their number is drastically increasing.

According to the United Nations Population Fund, 2020, the number of elderly people in the Asia-Pacific region is growing at an unprecedented rate and is at the forefront of global aging. By 2050, 1 in 4 people in Asia and the Pacific will be over 60 years old. The number of adults (over 60) in the region may triple between 2010 and 2050, reaching an estimated 1.3 million people.

Due to the large number of people suffering from these disorders, the market studied is growing. Furthermore, the launch of several technologically advanced products is boosting the market growth. For instance, in 2019, OMRON Healthcare launched Electronic Nerve Stimulator (model HV-F013), equipped with OMRON's Transcutaneous Electrical Nerve Stimulation (TENS) technology in India. The rising demand for and adoption of wireless portable muscle stimulators and their compatibility with smartphones create a lucrative opportunity in the muscle stimulators market.

Key Market Trends

The Pain Management ​Segment is Expected to Witness Healthy Growth in the Future.

Rehabilitation of patients with COVID-19 (C-19) after long-term treatment (ICU) is complex and challenging for patients suffering from a wide range of physiological disabilities affecting respiratory, cardiovascular, nerve, intestinal, and skeletal muscle function. Paralysis of the skeletal and respiratory muscles, commonly referred to as a weakened ICU (ICUAW), occurs in approximately 40% of normal patients admitted to the ICU. The ability to walk and engage in activities of daily living and return to daily life is severely impaired. Neuromuscular stimulation (NMES) is a technique in which small electrical impulses are used in the skeletal muscle to create contractions when it is difficult or impossible for people to start. NMES is associated with benefits that include improved strength and muscle function, improved bone strength, improved blood flow, and reduced edema. Furthermore, the stimulators are used in the pain management of COVID-29 patients, and hence, the segment is expected to grow due to the pandemic.

One of the most common forms of electrical stimulation used in pain management is transcutaneous electrical nerve stimulation, which provides temporary pain relief. Electrical nerve stimulation and electrothermal therapy are used to relieve pain associated with a variety of conditions, including back pain. Intradiscal electrothermal therapy (IDET) is a form of treatment for people with low back pain caused by intervertebral disc problems.

Furthermore, the increasing prevalence of conditions like arthritis, back pain, migraine, etc., are boosting the segment growth. According to WHO, 2021, the global prevalence of rheumatoid arthritis ranges from 0.3 to 1%, and it is more common in women and in developed countries. More than 23 million of the population are living with rheumatoid arthritis globally, and 1 in 100 people get rheumatoid arthritis, which can cause serious disablement issues if it goes undiagnosed and untreated. The estimates are predicted to double by 2030 due to the booming geriatric population.

North America is Expected to Hold a Significant Share in the Market in the Forecast Period

The region has been impacted hugely by the pandemic. The governments have taken measures to combat the pandemic in various forms. The market during the pandemic has been positively impacted in the region. FDA awarded a first-of-its-kind emergency use authorization to a respiratory muscle stimulator device designed to help wean COVID-19 patients requiring mechanical ventilation off of a ventilator.

North America is expected to hold a significant market share due to the growing healthcare expenditure for innovation and development of medical devices, increasing musculoskeletal disorders, and the presence of well-established healthcare infrastructure.

According to the Arthritis Society, 2021, about 20% of the population, that is 1 in 5 people, have arthritis in Canada. Pain affects a greater number of US citizens than diabetes, heart disease, and cancer combined. Pain is cited as the most common reason for US citizens to access the healthcare system. It is the leading cause of disability and a major contributor to healthcare costs.​The huge burden of target diseases is boosting the market growth in the region.

Furthermore, the launches in the region give the region a cutting edge over others. In June 2019, the FDA granted De Novo clearance to a prescription nerve stimulation device, the IB-Stim device, which is a single-use electrical nerve stimulator for the reduction of functional abdominal pain, made by Innovative Health Solutions. The device is intended for use by adolescents and teens with irritable bowel syndrome, in combination with other therapies.

Competitive Landscape

The muscle stimulator market is fragmented and competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies currently dominating the market are Beurer, NeuroMetrix Inc., DJO Global, EMS Physio Ltd, Zynex Medical, BioMedical Life Systems, and Omron Healthcare Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Musculoskeletal Disorders
    • 4.2.2 Technological Advancements
    • 4.2.3 Growing Preference Among Physiotherapists
  • 4.3 Market Restraints
    • 4.3.1 Availability of Cost-efficient Alternative Therapies
    • 4.3.2 Stringent Regulatory Policies and Safety Concerns
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Neuromuscular Electrical Stimulation
    • 5.1.2 Functional Electrical Stimulation
    • 5.1.3 Transcutaneous Electrical Nerve Stimulation
    • 5.1.4 Interferential
    • 5.1.5 Other Product Types
  • 5.2 By Modality
    • 5.2.1 Handheld
    • 5.2.2 Portable
  • 5.3 By Application
    • 5.3.1 Neurological Disorders
    • 5.3.2 Pain Management
    • 5.3.3 Musculoskeletal Disorders
    • 5.3.4 Others Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Beurer GmbH
    • 6.1.2 NeuroMetrix Inc.
    • 6.1.3 DJO Global
    • 6.1.4 EMS Physio Ltd
    • 6.1.5 Zynex Medical
    • 6.1.6 BioMedical Life Systems
    • 6.1.7 Omron Healthcare Inc.
    • 6.1.8 Liberate Medical
    • 6.1.9 Innovative Health Solutions
    • 6.1.10 Abbott Laboratories
    • 6.1.11 RS Medical Inc.
    • 6.1.12 Mettler Electronics Corp.
    • 6.1.13 Tone-A-Matic
    • 6.1.14 Zimmer MedizinSysteme GmbH
    • 6.1.15 EMS Physio Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q